GI-301
Scope
Date
~
-
Mergers & AcquisitionsKorea Zinc to sell $301 mn in CPs amid management feud with MBK
Korea Zinc Inc., the world’s top zinc and lead smelter, is set to sell 400 billion won ($300.9 million) in commercial papers, its first fundra...
Sep 25, 2024 (Gmt+09:00)
-
Bio & PharmaGI Innovation transfers allergy treatment tech to Japan
South Korea's GI Innovation Inc. announced on Monday it has transferred its allergy treatment "GI-301" to the Japanese pharmaceutical company Maruho...
Oct 16, 2023 (Gmt+09:00)
-
Bio & PharmaGI Innovation seeks to license allergy therapy to Japan in 2023
South Korea’s GI Innovation Inc. aims to complete licensing of its allergic diseases treatment candidate to a Japanese drug company by year's ...
Jul 17, 2023 (Gmt+09:00)
-
IPOsS.Korean biotech GI Innovation's IPO draws tepid market interest
South Korean biotech GI Innovation Inc. is slated to debut on the local public market at less than half of its pre-IPO investment value, facing luke...
Mar 20, 2023 (Gmt+09:00)
-
Bio & PharmaGI Cell wins approval for human cell management from Korean regulator
GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...
Dec 27, 2022 (Gmt+09:00)
-
Bio & PharmaS. Korea's GI Cell, Japanese partner to study cell therapy for blood cancer
South Korea's GI Cell, the cell therapy affiliate of GI Innovation, on Tuesday said it signed an agreement with Optieum Biotechnologies of Japan on ...
Dec 14, 2022 (Gmt+09:00)
Latest News
- 1 BYD’s Atto 3 overtakes Tesla’s Model Y as best-selling EV in South Korea
- 2 Korea’s top cinema chains seek merger to counter box office slump
- 3 S.Korea’s GEPS to commit $143 million to foreign mid-cap buyout funds
- 4 CJ CheilJedang to open $72 mn dumpling plant in Japan
- 5 LG Electronics breaks ground on $600 million home appliance plant in India
